BDBM593226 N-((1R,4R)-4-(((2-((5-chloro-1-(2- hydroxyethyl)-1H-pyrazol-4- yl)amino)-5-fluoropyrimidin-4- yl)oxy)methyl)cyclohexyl) acetamide::US11578061, Example 204
SMILES CC(=O)N[C@H]1CC[C@H](COc2nc(Nc3cnn(CCO)c3Cl)ncc2F)CC1
InChI Key InChIKey=QWFSGNVRSGPJQK-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 593226
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [970-2527](Human)
Halia Therapeutics
US Patent
Halia Therapeutics
US Patent
Affinity DataIC50: 50nMAssay Description:LRRKtide substrate (peptide sequence RLGRDKYKTLRQIRQ, derived from human ezrin [amino acids 561-573], moesin [amino acids 539-553] and radixin [amino...More data for this Ligand-Target Pair
